Rani Therapeutics Holdings Inc - Ordinary Shares Class A

NASDAQ:RANI 3:59:54 PM EDT

20.22

+0.28 (+1.40%)

Market Cap (Intraday)	398.61M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.63 Million
Adjusted EPS	-$0.18

See more estimates

10-Day MA	$19.68
50-Day MA	$18.81
200-Day MA	N/A

See more pivots

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Stock, NASDAQ:RANI

2051 Ringwood Avenue, San Jose, California 95131

United States of America

Phone: +1.408.457.3700

Number of Employees:

http://www.ranitherapeutics.com

Description

Rani Therapeutics Holdings, Inc. operates as a clinical stage bio-therapeutics company providing technologies to enable the development of orally administered biologics. It offers RaniPill capsule, an orally ingestible pill for the administration of a broad range of biologics. The company was founded by Mir Imran on April 6, 2021 and is headquartered in San Jose, CA.